TERIFLUNOMIDE
These highlights do not include all the information needed to use TERIFLUNOMIDE TABLETS safely and effectively. See full prescribing information for TERIFLUNOMIDE TABLETS. TERIFLUNOMIDE tablets, for oral use INITIAL U.S. APPROVAL: 2012
8c1bc23b-a62b-4172-a603-8b97761514b4
HUMAN PRESCRIPTION DRUG LABEL
Feb 6, 2023
Alembic Pharmaceuticals Inc.
DUNS: 079288842
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
TERIFLUNOMIDE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (13)
TERIFLUNOMIDE
Product Details
FDA regulatory identification and product classification information